Researcher.Life Logo

Expert Opinion on Pharmacotherapy : Impact Factor & More

eISSN: 1744-7666pISSN: 1465-6566

Aims and Scope of Expert Opinion on Pharmacotherapy

Expert Opinion on Pharmacotherapy is a peer-reviewed medical journal publishing review articles and original papers on new pharmacotherapies. It is published by Informa and the editor-in-chief is Dimitri P. Mikhailidis (Royal Free Hospital). Less

Key Metrics

CiteScore
5.5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.99
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Pharmacotherapy

Expert Opinion on Pharmacotherapy Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Pharmacotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Pharmacotherapy

Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer’s disease
  • 24 Apr 2026
  • Expert Opinion on Pharmacotherapy
Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases
  • 19 Apr 2026
  • Expert Opinion on Pharmacotherapy
New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin
  • 18 Apr 2026
  • Expert Opinion on Pharmacotherapy
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest
  • 17 Apr 2026
  • Expert Opinion on Pharmacotherapy
Optimizing the use of novel systemic therapies in atopic dermatitis: an insight into therapeutic transitions
  • 16 Apr 2026
  • Expert Opinion on Pharmacotherapy
Pancreatic cancer: emerging small molecule pharmacotherapies
  • 14 Apr 2026
  • Expert Opinion on Pharmacotherapy
Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer’s disease
  • 24 Apr 2026
  • Expert Opinion on Pharmacotherapy
Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases
  • 19 Apr 2026
  • Expert Opinion on Pharmacotherapy
New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin
  • 18 Apr 2026
  • Expert Opinion on Pharmacotherapy
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest
  • 17 Apr 2026
  • Expert Opinion on Pharmacotherapy
Optimizing the use of novel systemic therapies in atopic dermatitis: an insight into therapeutic transitions
  • 16 Apr 2026
  • Expert Opinion on Pharmacotherapy
Pancreatic cancer: emerging small molecule pharmacotherapies
  • 14 Apr 2026
  • Expert Opinion on Pharmacotherapy

FAQs on Expert Opinion on Pharmacotherapy